Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Current Assets (2016 - 2026)

Apyx Medical filings provide 16 years of Current Assets readings, the most recent being $58.5 million for Q4 2025.

  • On a quarterly basis, Current Assets rose 3.6% to $58.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $58.5 million, a 3.6% increase, with the full-year FY2025 number at $58.5 million, up 3.6% from a year prior.
  • Current Assets hit $58.5 million in Q4 2025 for Apyx Medical, up from $48.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $70.4 million in Q4 2023 to a low of $43.0 million in Q4 2022.
  • Median Current Assets over the past 5 years was $53.8 million (2022), compared with a mean of $55.1 million.
  • Biggest five-year swings in Current Assets: dropped 29.25% in 2022 and later skyrocketed 63.74% in 2023.
  • Apyx Medical's Current Assets stood at $60.7 million in 2021, then fell by 29.25% to $43.0 million in 2022, then skyrocketed by 63.74% to $70.4 million in 2023, then dropped by 19.79% to $56.4 million in 2024, then grew by 3.6% to $58.5 million in 2025.
  • The last three reported values for Current Assets were $58.5 million (Q4 2025), $48.8 million (Q3 2025), and $49.9 million (Q2 2025) per Business Quant data.